Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction
Journal of Innate Immunity · 2023 · 15 (1) · 548-561
DOI: 10.1159/000530284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, online erschienen am 17.04.2023. Verfasst von Jianmin Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK. Hauptthemen laut MEDLINE: Heart Diseases, Receptors, Formyl Peptide, Sepsis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, British Heart Foundation.
Themen: Sepsis
Abstract (Originalsprache)
Using a global formyl peptide receptor (Fpr) 2 knockout mouse colony, we have reported the modulatory properties of this pro-resolving receptor in polymicrobial sepsis. Herein, we have used a humanized FPR2 (hFPR2) mouse colony, bearing an intact or a selective receptor deficiency in myeloid cells to dwell on the cellular mechanisms. hFPR2 mice and myeloid cell-specific hFPR2 KO (KO) mice were subjected to cecal ligation and puncture (CLP)-induced polymicrobial sepsis. Compared with hFPR2 mice, CLP caused exacerbated cardiac dysfunction (assessed by echocardiography), worsened clinical outcome, and impaired bacterial clearance in KO mice. This pathological scenario was paralleled by increased recruitment of pro-inflammatory monocytes and reduced M2-like macrophages within the KO hearts. In peritoneal exudates of KO mice, we quantified increased neutrophil and MHC II+ macrophage numbers but decreased monocyte/macrophage and MHC II- macrophage recruitment. hFPR2 upregulation was absent in myeloid cells, and local production of lipoxin A4 was reduced in septic KO mice. Administration of the FPR2 agonist annexin A1 (AnxA1) improved cardiac function in hFPR2 septic mice but had limited beneficial effects in KO mice, in which the FPR2 ligand failed to polarize macrophages toward an MHC II- phenotype. In conclusion, FPR2 deficiency in myeloid cells exacerbates cardiac dysfunction and worsens clinical outcome in polymicrobial sepsis. The improvement of cardiac function and the host immune response by AnxA1 is more effective in hFPR2-competent septic mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK.
- Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London, UK.
Förderung
- Wellcome Trust
- Medical Research Council
- British Heart Foundation
Zitieren
APA
Chen, J., Austin-Williams, S., O'Riordan, C. E., Claria-Ribas, P., Sugimoto, M. A., Norling, L. V., Thiemermann, C., & Perretti, M. (2023). Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction. Journal of Innate Immunity, 15(1), 548-561. https://doi.org/10.1159/000530284
Vancouver
Chen J, Austin-Williams S, O'Riordan CE, Claria-Ribas P, Sugimoto MA, Norling LV, et al. Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction. Journal of Innate Immunity. 2023;15(1):548-561. doi:10.1159/000530284
BibTeX
@article{Chen2023,
author = {Chen, Jianmin and Austin-Williams, Shani and O'Riordan, Caroline Elizabeth and Claria-Ribas, Pol and Sugimoto, Michelle A and Norling, Lucy V and Thiemermann, Christoph and Perretti, Mauro},
title = {Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction},
journal = {Journal of Innate Immunity},
year = {2023},
volume = {15},
number = {1},
pages = {548--561},
doi = {10.1159/000530284}
}
EUVIMED